XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.450
-0.050 (-1.43%)
Aug 27, 2025, 4:00 PM - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $105.18 million as of August 27, 2025. Its market cap has decreased by -47.59% in one year.
Market Cap
105.18M
Enterprise Value
-47.76M
1-Year Change
-47.59%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $105.18M, a decrease of -85.74%. That is a compound annual growth rate of -17.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 106.70M | -11.38% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 624.22B |
| Johnson & Johnson | 429.67B |
| AbbVie | 366.65B |
| UnitedHealth Group | 276.10B |
| Novo Nordisk | 255.49B |
| AstraZeneca | 251.25B |
| Novartis AG | 244.09B |
| Abbott Laboratories | 229.51B |